These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3042616)

  • 1. Immunodominance in T lymphocyte recognition.
    Berzofsky JA
    Immunol Lett; 1988 Jun; 18(2):83-92. PubMed ID: 3042616
    [No Abstract]   [Full Text] [Related]  

  • 2. The biologic roles of CD2, CD4, and CD8 in T-cell activation.
    Bierer BE; Sleckman BP; Ratnofsky SE; Burakoff SJ
    Annu Rev Immunol; 1989; 7():579-99. PubMed ID: 2653377
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of CD4 and CD8 in enhancing T-cell responses to antigen.
    Parnes JR; von Hoegen P; Miceli MC; Zamoyska R
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():649-55. PubMed ID: 2518008
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms influencing the immunodominance of T cell determinants.
    Adorini L; Appella E; Doria G; Nagy ZA
    J Exp Med; 1988 Dec; 168(6):2091-104. PubMed ID: 2462005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen processing and CD4+ T cell depletion in AIDS.
    Germain RN
    Cell; 1988 Aug; 54(4):441-4. PubMed ID: 2969773
    [No Abstract]   [Full Text] [Related]  

  • 6. CD8+ T cell response to Mls-1a determinants involves major histocompatibility complex class II molecules.
    Chvatchko Y; MacDonald HR
    J Exp Med; 1991 Mar; 173(3):779-82. PubMed ID: 1825506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.
    Germain RN
    Cell; 1994 Jan; 76(2):287-99. PubMed ID: 8293464
    [No Abstract]   [Full Text] [Related]  

  • 8. Endogenous peptides associated with MHC class II and selection of CD4 T cells.
    Rudensky AY
    Semin Immunol; 1995 Dec; 7(6):399-409. PubMed ID: 8775465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex.
    Robey E; Ramsdell F; Elliott J; Raulet D; Kioussis D; Axel R; Fowlkes BJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):608-12. PubMed ID: 1824875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of contrasuppression is restricted by genes mapping to the IgH locus.
    Green DR; Chue B; Flood PM
    Immunol Res; 1988; 7(1):82-92. PubMed ID: 2897413
    [No Abstract]   [Full Text] [Related]  

  • 11. Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo.
    Nikcevich KM; Kopielski D; Finnegan A
    J Immunol; 1994 Aug; 153(3):1015-26. PubMed ID: 7517970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific T cell recognition of kinetic isomers in the binding of peptide to class II major histocompatibility complex.
    Rabinowitz JD; Tate K; Lee C; Beeson C; McConnell HM
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8702-7. PubMed ID: 9238041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The co-receptor function of murine CD4.
    Janeway CA; Rojo J; Saizawa K; Dianzani U; Portoles P; Tite J; Haque S; Jones B
    Immunol Rev; 1989 Jun; 109():77-92. PubMed ID: 2670749
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands.
    Wong P; Barton GM; Forbush KA; Rudensky AY
    J Exp Med; 2001 May; 193(10):1179-87. PubMed ID: 11369789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of class II antigens in different routes of alloactivation.
    Sutherland R; Heath W; Boyle W
    Transplant Proc; 1986 Apr; 18(2):298-301. PubMed ID: 2938317
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of the mechanisms of human B cell activation. V. The role of Ia-like antigens and T cell differentiation antigens in the activation of B cells by pokeweed mitogen].
    Suzuki N; Sakane T; Tsunematsu T
    Arerugi; 1985 Jul; 34(7):450-9. PubMed ID: 3933459
    [No Abstract]   [Full Text] [Related]  

  • 17. Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice.
    Barzaga-Gilbert E; Grass D; Lawrance SK; Peterson PA; Lacy E; Engelhard VH
    J Exp Med; 1992 Jun; 175(6):1707-15. PubMed ID: 1534116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of lymphokine release involving a novel form of T-T collaboration.
    Gill RG; Lafferty KJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2700-2. PubMed ID: 2495673
    [No Abstract]   [Full Text] [Related]  

  • 20. Peptide interactions with class I and II MHC encoded molecules.
    Pecht I
    Isr J Med Sci; 1994 Mar; 30(3):28-31. PubMed ID: 7514162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.